BTC 
ETH 
BNB 
XRP 
SOL 
TRX Nurix shares fall after Sanofi scraps co-developed eczema drug
Investor's Business Daily reports that Nurix Therapeutics shares crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug the two companies were codeveloping. The post states the two firms diverged and one broke out on the news.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Nurix Therapeutics shares crashed after Sanofi scrapped an experimental eczema drug the two were codeveloping.
“Shares of Nurix Therapeutics crashed Wednesday after Sanofi unexpectedly scrapped an experimental eczema drug”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-04 15:20 UTC. Labels are computed from the sources, not by the model.